Introduction/Objective: Medication abortion is a common experience for women in the United States, now totaling over 50% of all abortions. The purpose of this exploratory analysis is to understand women's medication abortion and abortion pill reversal decision-making experiences, with a particular focus on their communication with their medical providers. Methods: We surveyed women who contacted Heartbeat International to inquire about abortion pill reversal. Eligible women had to complete a minimum of the 2-week progesterone protocol in order to answer the questions on the electronic survey about their medication abortion and abortion pill reversal decisions. We assessed decision difficulty using a Likert scale and provider communication using the Questionnaire on the Quality of Physician–Patient (QQPPI) and analyzed women's narratives about their experiences using thematic analysis. Results: Thirty-three respondents met the eligibility criteria and filled out the QQPPI and decision-difficulty scales. Using the QQPPI scale, women scored their communication with their APR providers as significantly better than their communication with their abortion providers (p < 0.0001). Women reported that choosing medication abortion was significantly more difficult than choosing abortion pill reversal (p < 0.0001). White women, women with college degrees, and women who were not in a relationship with the father of the child reported more difficulty in choosing APR. Conclusion: As the number of women who contact the national hotline to inquire about abortion pill reversal increases, the need to understand the experiences of this growing population of women becomes more salient. This need is particularly important for health care providers who prescribe medication abortion and abortion pill reversal. The quality of the physician-patient interaction is essential to providing effective medical care to pregnant women.
AlvarezCimmiaron F.WolfeBrooke H.ScharpKristina M.. 2022. “Identity (Re)Constructions in Mothers’ Online Stories About Terminating Wanted Pregnancies Due to Health Complications.” Health Communication37 (6): 668–676. https://doi.org/10.1080/10410236.2020.1862448.
3.
BieberChristianeMüllerKnut G.NicolaiJenniferHartmannMechthildEichWolfgang. 2010. “How Does Your Doctor Talk with You? Preliminary Validation of a Brief Patient Self-Report Questionnaire on the Quality of Physician–Patient Interaction.” Journal of Clinical Psychology in Medical Settings17 (2): 125–136. https://doi.org/10.1007/s10880-010-9189-0.
4.
BiggsM. AntoniaRalphLaurenRaifmanSarahFosterDiana G.GrossmanDaniel. 2019. “Support for and Interest in Alternative Models of Medication Abortion Provision among a National Probability Sample of U.S. Women.” Contraception99 (2): 118–124. https://doi.org/10.1016/j.contraception.2018.10.007.
ChipidzaFallon E.WallworkRachel S.SternTheodore A.. 2015. “Impact of the Doctor-Patient Relationship.” The Primary Care Companion For CNS Disorders17 (5). https://doi.org/10.4088/PCC.15f01840.
8.
ChorJulieTuskenMeganLymanPhoebeGilliamMelissa. 2016. “Factors Shaping Women’s Pre-Abortion Communication with Their Regular Gynecologic Care Providers.” Women’s Health Issues26 (4): 437–441. https://doi.org/10.1016/j.whi.2016.03.003.
9.
DarneyBlair GPowellBillAndersenKathyrnBaumSarah EBlanchardKellyGerdtsCaitlinMontaguDominicChakrabortyNirali MKappNathalie. 2018. “Quality of Care and Abortion: Beyond Safety.” BMJ Sexual & Reproductive Health44 (3): 159–160. https://doi.org/10.1136/bmjsrh-2018-200060.
10.
DavenportMaryDelgadoGeorgeHarrisonMatthew PKhauvVeronica. 2017. “Embryo Survival After Mifepristone: A Systematic Review of the Literature.” Issues in Law & Medicine32 (1): 3–18.
11.
DelgadoGeorgeCondlySteven JDavenportMaryTinnakornsrisuphapThidaratMackJonathanKhauvVeronicaZhouPaul S. 2018. “A Case Series Detailing the Successful Reversal of the Effects of Mifepristone Using Progesterone.” Issues in Law & Medicine33 (1): 21–31.
12.
FinerLawrence BFrohwirthLori FDauphineeLindsay ASinghSusheelaMooreAnn M. 2005. “Reasons U.S. Women Have Abortions: Quantitative and Qualitative Perspectives.” Perspectives on Sexual and Reproductive Health37 (3): 110–118. https://doi.org/10.1363/psrh.37.110.05.
13.
FrohwirthLoriColemanMicheleMooreAnn M.. 2018. “Managing Religion and Morality Within the Abortion Experience: Qualitative Interviews With Women Obtaining Abortions in the U.S.” World Medical & Health Policy10 (4): 381–400. https://doi.org/10.1002/wmh3.289.
14.
GatterMaryClelandKellyNucatolaDeborah L.. 2015. “Efficacy and Safety of Medical Abortion Using Mifepristone and Buccal Misoprostol Through 63 Days.” Contraception91 (4): 269–273. https://doi.org/10.1016/j.contraception.2015.01.005.
15.
GordonChristopherBeresinEugene V.. 2015. “The Doctor-Patient Relationship.” In Massachusetts General Hospital Comprehensive Clinical Psychiatry, edited by SternTheodore AFavaMaurizioWilensTimothy E.RosenbaumJerrold F.. 2nd ed., 1–7. London: Elsevier.
16.
GordonHoward S.SolankiPoojaBokhourBarbara G.GopalRavi K.. 2020. “‘I’m Not Feeling Like I’m Part of the Conversation’ Patients’ Perspectives on Communicating in Clinical Video Telehealth Visits.” Journal of General Internal Medicine35 (6): 1751–1758. https://doi.org/10.1007/s11606-020-05673-w.
17.
JoffeCarole.2013. “The Politicization of Abortion and the Evolution of Abortion Counseling.” American Journal of Public Health103 (1): 57–65. https://doi.org/10.2105/AJPH.2012.301063.
18.
JonesRachel K.JermanJenna. 2022. “Characteristics and Circumstances of U.S. Women Who Obtain Very Early and Second-Trimester Abortions.” PLOS One12 (1): e0169969. https://doi.org/10.1371/journal.pone.0169969.
KavanaughMegan L.JermanJennaFrohwirthLori. 2019. “‘It’s Not Something You Talk About Really’: Information Barriers Encountered by Women Who Travel Long Distances for Abortion Care.” Contraception100 (1): 79–84. https://doi.org/10.1016/j.contraception.2019.03.048.
21.
LippkeSoniaWienertJulianKellerFranziska MariaDerksenChristinaWelpAnnalenaKöttingLukasHofreuter-GätgensKerstin, et al.2019. “Communication and Patient Safety in Gynecology and Obstetrics - Study Protocol of an Intervention Study.” BMC Health Services Research19 (1): 908. https://doi.org/10.1186/s12913-019-4579-y.
22.
LongbonsTessa.2022. “Abortion Reporting: New York (2019).” August 5, 2022.
23.
Nicoloro-SantaBarbaraJenniferRosenthalLisaAuerbachMelissa v.KocisChristinaBussoCheyanneLobelMarci. 2017. “Patient-Provider Communication, Maternal Anxiety, and Self-Care in Pregnancy.” Social Science & Medicine190 (October): 133–140. https://doi.org/10.1016/j.socscimed.2017.08.011.
24.
PruskiMichalWhitehouseDominicBowSteven. 2022. “The Right to Choose to Abort an Abortion: Should pro-Choice Advocates Support Abortion Pill Reversal?” The New Bioethics28 (3): 252–267. https://doi.org/10.1080/20502877.2022.2073857.
25.
RaffertyKatherine A.LongbonsTessa. 2021. “#AbortionChangesYou: A Case Study to Understand the Communicative Tensions in Women’s Medication Abortion Narratives.” Health Communication36 (12): 1485–1494. https://doi.org/10.1080/10410236.2020.1770507.
26.
RaymondElizabeth G.GrossmanDanielMarkAliceUpadhyayUshma D.DeanGillianCreininMitchell D.CoplonLeah, et al.2020. “Commentary: No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond.” Contraception101 (6): 361–366. https://doi.org/10.1016/j.contraception.2020.04.005.
27.
StudnickiJ.LongbonsT.HarrisonD. J.SkopI.CirucciC.ReardonD. C.CraverC.FisherJ. W.TsulukidzeM.. 2022. “A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room Are a Risk Factor for Hospitalization.” Health Services Research and Managerial Epidemiology9 (January): 233339282211031. https://doi.org/10.1177/23333928221103107.
28.
SwicaYaelRaghavanSheilaBrackenHillaryDabashRashaWinikoffBeverly. 2011. “Review of the Literature on Patient Satisfaction with Early Medication Abortion Using Mifepristone and Misoprostol.” Expert Review of Obstetrics and Gynecology6 (4): 451–468. https://doi.org/10.1586/eog.11.37.
29.
SwicaYaelChongEricaMiddletonTamerPrineLindaGoldMarjiSchreiberCourtney A.WinikoffBeverly. 2013. “Acceptability of Home Use of Mifepristone for Medical Abortion.” Contraception88 (1): 122–127. https://doi.org/10.1016/j.contraception.2012.10.021.
30.
TierneyKatherine I.2019. “Abortion Underreporting in Add Health: Findings and Implications.” Population Research and Policy Review38 (3): 417–428. https://doi.org/10.1007/s11113-019-09511-8.
31.
WeinbergerSteven E.LawrenceHal C.HenleyDouglas E.AldenErrol R.HoytDavid B.. 2012. “Legislative Interference with the Patient–Physician Relationship.” New England Journal of Medicine367 (16): 1557–1559. https://doi.org/10.1056/NEJMsb1209858.
32.
WingoErinRalphLauren J.KallerShellyBiggsM. Antonia. 2021. “Abortion Method Preference among People Presenting for Abortion Care.” Contraception103 (4): 269–275. https://doi.org/10.1016/j.contraception.2020.12.010.
